| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 05/06/2010 | US20100115636 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex |
| 05/06/2010 | US20100115635 Methods for Assessing the Delivery of Exogenous Agents |
| 05/06/2010 | US20100113867 Methods for maintaining genetic stability of inbred animal strains |
| 05/06/2010 | US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/06/2010 | US20100113351 Therapeuting Compositions Comprising an RNAi Agent and a Neurotrophic Factor and Methods of Use Thereof |
| 05/06/2010 | US20100111991 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 05/06/2010 | US20100111922 Animal model and use of 17beta-hydroxysteroid dehydrogenase type 7 in the diagnosis of anencephaly |
| 05/06/2010 | US20100107987 Production of bivalve tetraploid mollusks from diploid parents |
| 05/05/2010 | EP2182064A1 Gene expressed in prostate cancer |
| 05/05/2010 | EP2181589A1 Neurotoxic sterol glycosides |
| 05/05/2010 | EP1248803B1 Nogo receptor-mediated blockade of axonal growth |
| 05/05/2010 | EP0973928B1 Dna-based transposon system for the introduction of nucleic acid into dna of a cell |
| 05/05/2010 | EP0854917B1 Transgenic non-human animals capable of producing heterologous antibodies |
| 05/05/2010 | CN201444826U Ventilated predatory mite release bag |
| 05/05/2010 | CN201444825U Anastatus japonicus mass propagation cabinet |
| 05/05/2010 | CN201444824U Hatchery of terrapins |
| 05/05/2010 | CN1909779B Method for sifting nerve active compound and related nerve plasticity |
| 05/05/2010 | CN101700007A Cage-type earthworm breeding method |
| 05/04/2010 | US7709696 Transgenic mice generated by transposition and uses thereof |
| 05/04/2010 | US7709695 Transgenic mouse expressing arctic mutation E693G |
| 05/04/2010 | US7709270 Using platelete derived growth factor as tool in detection of modulators for prevention and treatment of cell proliferative disorders |
| 05/04/2010 | CA2448863C Increased and sustained in vivo gene expression using a nucleic acid, histone, and amphipathic compound composition |
| 05/04/2010 | CA2140638C Generation of xenogeneic antibodies |
| 04/30/2010 | CA2665773A1 Neurotoxic sterol glycosides |
| 04/29/2010 | WO2010047676A1 An immunocompetent xenograft model |
| 04/29/2010 | WO2010047423A1 Method for introducing mutated gene, gene having mutation introduced therein, cassette for introducing mutation, vector for introducing mutation, and knock-in non-human mammal |
| 04/29/2010 | WO2010047293A1 Method for spinning silk from cocoon of silkworm expressing foreign gene, and product produced by employing the method |
| 04/29/2010 | WO2010046519A1 Animal model of human angiogenesis and applications thereof |
| 04/29/2010 | WO2010008562A3 Methods and materials for producing transgenic animals |
| 04/29/2010 | US20100107265 Double-muscling in mammals |
| 04/29/2010 | US20100107264 Development of influenza a antivirals |
| 04/29/2010 | US20100107263 C-reactive protein (crp) knockout mouse |
| 04/29/2010 | US20100105121 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/29/2010 | US20100105090 Secreted luciferase mluc7 and use thereof |
| 04/29/2010 | US20100104535 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 04/28/2010 | EP2180307A2 Improved flow cytometer nozzle |
| 04/28/2010 | EP2180046A1 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms |
| 04/28/2010 | EP2179045A2 Cartilage-specific expression |
| 04/28/2010 | EP2178915A2 Anti cd37 antibodies |
| 04/28/2010 | EP2178363A2 Methods of improving a genomic marker index of dairy animals and products |
| 04/28/2010 | EP1673450B1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 04/28/2010 | EP1427828B1 Random integration of a polynucleotide after in vivo linearization |
| 04/28/2010 | EP1356067B1 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs |
| 04/28/2010 | CN1813066B Novel beta-actin and rps21 promoters and uses thereof |
| 04/28/2010 | CN1768581B Method for screening tender pork and its detection kit |
| 04/27/2010 | US7705199 Using modulators of toll-like receptor and/or uncooridinated protein activities as therapeutic agents in treatment of diabetes, multiple sclerosis, rheumatoid arthritis and addison's diseases |
| 04/27/2010 | US7705198 screening agent for ability to modulate energy expenditure by administering agent to transgenic mouse whose genome comprises homozygous disruption of endogenous KSR-2 gene, where no KSR-2 protein is expressed and said mouse exhibits a phenotype comprising increased obesity and reduced energy expenditure |
| 04/27/2010 | US7705197 Embryo development and survival |
| 04/27/2010 | US7705195 Screening method |
| 04/27/2010 | US7704970 DNA vaccination for treatment of autoimmune disease |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704698 Human T2R51 taste receptor and related assays for identifying bitter taste modulators |
| 04/22/2010 | US20100100979 Biomarker specific for cancer |
| 04/22/2010 | US20100100978 RNAi MEDIATED EXPRESSION INHIBITION OF A CHOLINERGIC PROTEIN |
| 04/22/2010 | US20100100977 Probe for visualizing cell-cycle |
| 04/22/2010 | US20100100976 Methods and compositions related to apobec-1 expression |
| 04/22/2010 | US20100100975 Silk proteins |
| 04/22/2010 | US20100100974 Models of Malignant Brain Cancer, and Therapeutic siRNAs Against Oncogenic Signaling Pathways, and Methods and Kits for Uses Therefor |
| 04/22/2010 | US20100099740 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 04/22/2010 | US20100099638 Immunocompetent xenograft model |
| 04/22/2010 | US20100099167 for producing beta-alanine, pantothenate, 3-hydroxypropionic acid, as well as other organic compounds |
| 04/22/2010 | US20100099111 Antibodies against a protein entitled 161p2f10b |
| 04/22/2010 | US20100098694 Antibodies to cd40 |
| 04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/21/2010 | EP2177606A2 N-deoxyribosyltransferases from lactobacillus, corresponding nucleotide sequences and their applications |
| 04/21/2010 | EP2176290A1 Transgenic animal model for modelling pathological anxiety, a method for identifying compounds for treatment of diseases or disorders caused by pathological anxiety and a method for using wfsl protein as a target for identifying effective compounds against pathological anxiety |
| 04/21/2010 | EP1660662B1 Regulatable gene expression in mammalian cells and mammals |
| 04/21/2010 | CN101696075A Method for biologically digesting and recycling pig large intestine excrement and hair and intestine wastes |
| 04/21/2010 | CN101695340A Method for breeding aseptic fly maggots |
| 04/21/2010 | CN101695294A Method for breeding froglets of Chinese forest frogs in North Guangdong |
| 04/21/2010 | CN101366628B Tentaculum electric potential method for dark branchia cockchafer with lamelliform tentaculum |
| 04/20/2010 | US7700825 Recombinant constructs and transgenic fluorescent ornamental fish therefrom |
| 04/20/2010 | US7700824 Methods |
| 04/20/2010 | US7700823 Using animal model which expresses mutated presenilin proteins as diagnostic tool in monitoring/screening modulator for treatment of nervous system disorders |
| 04/20/2010 | US7700822 Preparing transgenic animal model for diagnosis, prevention and treatment of atherosclerosis, hormonal imbalances, nervous system, skin, cardiovascular, cancer and vision disorders; drug screening |
| 04/20/2010 | US7700749 Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer |
| 04/20/2010 | US7700742 Antibodies to insulin-like growth factor I receptor |
| 04/20/2010 | US7700724 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 04/20/2010 | US7700719 Mutant protofibril for active immunisation; synuclein genes, proteins; point mutations; Parkinson's disease; dementia; host cells |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700547 Preventing airway mucus production by administration of EGF-R antagonists |
| 04/20/2010 | US7700341 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/20/2010 | US7700304 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening |
| 04/20/2010 | US7700297 Artery- and vein-specific proteins and uses therefor |
| 04/20/2010 | US7700106 Therapeutic agent for ulcerative colitis |
| 04/20/2010 | US7700091 Bacterium for use as vehicle for gene transport and transfer to preferential organs or tissues; tissue engineering and targeted somatic transgenesis |
| 04/20/2010 | CA2200496C Genetic transformation using a parp inhibitor |
| 04/20/2010 | CA2181433C Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 04/20/2010 | CA2099562C Expression of active human protein c in mammary tissue of transgenic animals |
| 04/15/2010 | WO2010004052A3 Agonists of nr2f6 for immunosuppression |
| 04/15/2010 | US20100095391 Regulation of lipid droplet formation by modulation of fit1 and fit2 and uses thereof |
| 04/15/2010 | US20100095390 Aldolases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 04/15/2010 | US20100095389 Methods of maintaining genetic stability of inbred animal strains |
| 04/15/2010 | US20100095388 Erythropoietin-Producing Organoid Precursor, Production Method Thereof, and Method For Treating Erythropoietin-Related Disorder |
| 04/15/2010 | US20100095387 Methods and reagents for screening new drugs and for treating ion pump associated disorders and diseases |
| 04/15/2010 | US20100093867 Method Of Treating Genetic Disease Caused By Nonsense Mutation |
| 04/15/2010 | US20100092455 Novel anti-proliferation antibodies |
| 04/15/2010 | US20100092449 Treatment of Pompe's Disease |
| 04/14/2010 | EP2173160A1 Transgenic animals for assessing drug metabolism and toxicity |
| 04/14/2010 | EP1513397B1 Transgenic ungulates capable of human antibody production |